Table:
begin	end	state
1	40	cytoplasmic
41	63	transmembrane
64	81	non-cytoplasmic
82	101	transmembrane
102	157	cytoplasmic
158	180	transmembrane
181	185	non-cytoplasmic
186	204	transmembrane
205	270	cytoplasmic
271	296	transmembrane
297	297	non-cytoplasmic
298	312	transmembrane
313	316	non-cytoplasmic
317	611	cytoplasmic

Input:
>WP_055442190.1 NCBI__GCF_001418105.1:WP_055442190.1
MARQAPKSLKEAKKTNLRKSFSALVFIPRFFKEIWKTNKKLFLLSAFCRGIGAVLPVVIL
WVGKIIIDEIIVQTKGDASDLTLLWTYVAIEFGLIILSDLVSRAISLTDSLLGDSYSIDS
SVRIIKKTNQINISLLEDSEFYDKLERARTQTTGRVGLMSNALGEVQSLISILTLVAGLI
YFEPYLIILLVLSIIPSFINEIWFSQQQYSLARGWTAERRELDYLRFIGANDKTAKEIKL
FGLTDFVVDRFKNLSNEYYNLNKKLAVKRSALGFLFNVLGTLSYYGAYVFIIYRVISGVI
TLGELTFLSGAFNRLTRNLQDFFSKFTRITESSLYLKDYFDFLDISIAPSHKEDMPLPET
IQEGFEFKNVHFAYPGSENEILKGISFKMKAGEKLAFVGQNGAGKTTLTKLLLRFYEPTS
GEILLDGININRFDKAKYQEYFGVIFQDFFKYEFTVRENIAIGDISEIDNQSKIENAAEL
SLANEVVQDLKFGYDQQLGKRFAKGQELSGGQWQKVALARAYMKDAKVMILDEPTSALDA
KAESEVFDRFIGLTQFKTSVIISHRFSTVRQADRILVLEEGRVLEMGTHEELMKNQSLYA
DLFTLQAEGYQ

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server